| 000 | 01407 a2200301 4500 | ||
|---|---|---|---|
| 008 | 041203s xx 000 0 eng | ||
| 022 | _a1522-3191; | ||
| 050 | _aAC1.S5 | ||
| 082 | _a050 | ||
| 100 | _aSack, Kevin, | ||
| 245 | 2 |
_aA Dose of Denial. _cKevin Sack and Alicia Mundy. |
|
| 260 |
_bLos Angeles Times, _c2004. |
||
| 440 |
_aSIRS Enduring Issues 2005. _nArticle 74, _pBusiness, _x1522-3191; |
||
| 500 | _aArticles Contained in SIRS Enduring Issues 2005. | ||
| 500 | _aOriginally Published: A Dose of Denial, March 28, 2004; pp. A1+. | ||
| 520 | _aThis article presents the stories of people who suffered strokes after taking an over-the-counter cold medication containing phenylpropanolamine (PPA). The authors reveal that "the drug industry had spent more than two decades fending off growing evidence of a possible link between PPA and hemorrhagic stroke" (LOS ANGELES TIMES).. | ||
| 599 | _aRecords created from non-MARC resource. | ||
| 650 | _aActions and defenses | ||
| 650 | _aCerebrovascular disease | ||
| 650 |
_aCerebrovascular disease _xPatients |
||
| 650 |
_aCold (Disease) _xTreatment |
||
| 650 |
_aDrugs _xNonprescription |
||
| 650 | _aPharmaceutical industry | ||
| 650 | _aPhenylpropanolamine | ||
| 610 |
_aUnited States _bFood and Drug Adm. |
||
| 710 |
_aProQuest Information and Learning Company _tSIRS Enduring Issues 2005, _pBusiness. _x1522-3191; |
||
| 942 | _c UKN | ||
| 999 |
_c36056 _d36056 |
||